Literature DB >> 32096477

Serum levels of interleukin-32 and interleukin-6 in granulomatosis with polyangiitis and microscopic polyangiitis: association with clinical and biochemical findings.

Joanna Krajewska Wojciechowska1, Katarzyna Kościelska-Kasprzak2, Wojciech Krajewski3, Krzysztof Morawski1.   

Abstract

BACKGROUND: Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis is an autoimmune disorder of unknown etiology with dysregulated cytokines levels.
OBJECTIVES: The main aim of this study was to assess the clinical correlation between antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, granulomatosis with polyangiitis (GPA) serum levels of the microscopic polyangiitis (MPA), serum levels of the proinflammatory cytokines, interleukin (IL)-32 and interleukin-6.
METHODS: Study included 71 patients, 47 with GPA and 24 with MPA. Serum IL-32 and IL-6 concentrations were analyzed in all patients, and compared with levels observed in 10 controls. IL-32 and IL-6 were evaluated using DuoSet and Quantikine HS ELISA, respectively. IL-32 and IL-6 concentrations were correlated with disease-related clinical and laboratory findings.
RESULTS: IL-32 and IL-6 levels were significantly higher in GPA and MPA than in controls, especially IL-32 levels in GPA were elevated. IL-32 concentrations correlated positively with anti-proteinase 3 - ANCA (PR3-ANCA) levels in GPA (P < 0.0001), and with anti-myeloperoxidase ANCA (MPO-ANCA) in MPA (P = 0.049). IL-32 levels correlated positively with disease activity in GPA and MPA (P < 0.0001). GPA patients with pulmonary, cutaneous, and musculoskeletal involvement presented the highest IL-6 serum levels. Cutaneous manifestations correlated positively with IL-6 levels in MPA patients (P = 0.05). ANCA-positive patients with GPA expressed significantly high IL-6 levels (P = 0.036). No significant difference in IL-32 values was observed between ANCA-positive and ANCA-negative patients.
CONCLUSIONS: Patients with GPA and MPA present higher serum IL-32 and IL-6 levels than controls. IL-32 levels correlate positively with disease activity.

Entities:  

Keywords:  ANCA; granulomatosis with polyangiitis; interleukin-32; interleukin-6; microscopic polyangiitis; vasculitis

Mesh:

Substances:

Year:  2019        PMID: 32096477     DOI: 10.1684/ecn.2019.0439

Source DB:  PubMed          Journal:  Eur Cytokine Netw        ISSN: 1148-5493            Impact factor:   2.737


  5 in total

1.  Genome-Wide DNA Methylation Profiling in CD8 T-Cells and Gamma Delta T-Cells of Asian Indian Patients With Takayasu Arteritis.

Authors:  Jayakanthan Kabeerdoss; Debashish Danda; Ruchika Goel; Hindhumathi Mohan; Sumita Danda; R Hal Scofield
Journal:  Front Cell Dev Biol       Date:  2022-06-23

Review 2.  Right atrial myxoma as the first manifestation of granulomatosis with polyangiitis, and a possible association with vascular endothelial growth factor (VEGF) and interleukin 6 (IL-6): a case report and review of the literature.

Authors:  Joel Corin; Amanda Carlsson; Björn Peters
Journal:  Eur J Med Res       Date:  2022-01-11       Impact factor: 2.175

Review 3.  Neutrophil Extracellular Traps in ANCA-Associated Vasculitis and Interstitial Lung Disease: A Scoping Review.

Authors:  Miriana d'Alessandro; Edoardo Conticini; Laura Bergantini; Paolo Cameli; Luca Cantarini; Bruno Frediani; Elena Bargagli
Journal:  Life (Basel)       Date:  2022-02-20

4.  COVID-19 and Immunological Dysregulation: Can Autoantibodies be Useful?

Authors:  Simona Pascolini; Antonio Vannini; Gaia Deleonardi; Michele Ciordinik; Annamaria Sensoli; Ilaria Carletti; Lorenza Veronesi; Chiara Ricci; Alessia Pronesti; Laura Mazzanti; Ana Grondona; Tania Silvestri; Stefano Zanuso; Marcello Mazzolini; Claudine Lalanne; Chiara Quarneti; Marco Fusconi; Fabrizio Giostra; Alessandro Granito; Luigi Muratori; Marco Lenzi; Paolo Muratori
Journal:  Clin Transl Sci       Date:  2021-01-20       Impact factor: 4.689

5.  IL-32 induces epithelial-mesenchymal transition by triggering endoplasmic reticulum stress in A549 cells.

Authors:  Ling Gong; Gang Liu; Honglan Zhu; Caihong Li; Pengmei Li; Changlu Liu; Hongbo Tang; Kaifeng Wu; Jie Wu; Daishun Liu; Xiaoping Tang
Journal:  BMC Pulm Med       Date:  2020-10-23       Impact factor: 3.317

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.